In this study, we employed the Library of Pharmacologically Active Compounds (LOPAC1280), a high-throughput screening platform containing well-characterized small molecules, to identify agents capable of selectively suppressing tumor growth and modulating immune-relevant pathways in MTAP-deficient cancer cells. The gene discussed is MTAP; the disease is neoplasm.